| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014912920 |
| P356 | DOI | 10.1186/SCRT381 |
| P8608 | Fatcat ID | release_pnqikau4svel3jtl4whrsgz3oa |
| P932 | PMC publication ID | 4056686 |
| P698 | PubMed publication ID | 24476362 |
| P5875 | ResearchGate publication ID | 259984279 |
| P2093 | author name string | Hung-Fat Tse | |
| Song-Yan Liao | |||
| P2860 | cites work | Stem cell treatment for acute myocardial infarction | Q24203736 |
| Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection | Q24631810 | ||
| Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells | Q24672061 | ||
| Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium | Q24677311 | ||
| Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes | Q27438164 | ||
| Induced regeneration--the progress and promise of direct reprogramming for heart repair | Q27687630 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. | Q28131663 | ||
| Generation of mouse induced pluripotent stem cells without viral vectors | Q29614342 | ||
| Mesenchymal stem cells | Q29619804 | ||
| Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 | ||
| RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 | ||
| Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | Q29620480 | ||
| Imaging survival and function of transplanted cardiac resident stem cells | Q30494736 | ||
| Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction | Q30496413 | ||
| Monitoring of bone marrow cell homing into the infarcted human myocardium | Q31162853 | ||
| Cardiomyocytes can be generated from marrow stromal cells in vitro | Q33843659 | ||
| Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors | Q33887795 | ||
| Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart | Q33892673 | ||
| Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function | Q33906844 | ||
| Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function | Q33941111 | ||
| Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair | Q34103630 | ||
| Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells | Q34105709 | ||
| Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats | Q34355730 | ||
| Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity | Q34631498 | ||
| Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells | Q35799278 | ||
| Mesenchymal stem cells: isolation and therapeutics | Q35877577 | ||
| Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial | Q36603453 | ||
| Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction | Q36630155 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial | Q36694346 | ||
| Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells | Q36793257 | ||
| Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells | Q36848798 | ||
| Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats | Q36861582 | ||
| Endothelial progenitor cells in neovascularization of infarcted myocardium | Q37066764 | ||
| Cardiac stem cells and myocardial disease | Q37206379 | ||
| Functional cardiomyocytes derived from human induced pluripotent stem cells | Q37341034 | ||
| Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function | Q37355668 | ||
| Stem cell therapy for heart failure: are arrhythmias a real safety concern? | Q37496407 | ||
| The existence of myocardial repair: mechanistic insights and enhancements | Q37625460 | ||
| Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. | Q37775670 | ||
| Immunomodulatory activity of mesenchymal stem cells. | Q37824486 | ||
| Embryonic stem cells for severe heart failure: why and how? | Q37992937 | ||
| Immunosuppressive properties of mesenchymal stem cells: advances and applications. | Q38003737 | ||
| Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium | Q38010814 | ||
| Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis | Q38021450 | ||
| Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension | Q39317535 | ||
| At a crossroad: cell therapy for cardiac repair | Q39514108 | ||
| Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice | Q39736437 | ||
| Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. | Q40173892 | ||
| Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization | Q40641800 | ||
| Stem cell-derived cardiomyocytes demonstrate arrhythmic potential | Q40707071 | ||
| Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts | Q41980314 | ||
| Purification and characterization of mouse hematopoietic stem cells | Q42065991 | ||
| Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling | Q42226249 | ||
| Cardiac stem cell therapy and the promise of heart regeneration | Q42575668 | ||
| Bone marrow tinctures for cardiovascular disease: lost in translation | Q42751683 | ||
| Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model | Q43659756 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction | Q44392643 | ||
| Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. | Q44960426 | ||
| Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium | Q45206400 | ||
| Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model | Q45218845 | ||
| Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction | Q45882845 | ||
| Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. | Q45992110 | ||
| Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension | Q46691696 | ||
| Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials | Q46700937 | ||
| Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction | Q47894537 | ||
| Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. | Q50541458 | ||
| Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. | Q50757237 | ||
| Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. | Q51011615 | ||
| Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. | Q52175867 | ||
| Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. | Q53518426 | ||
| Acute myocardial infarction | Q54069247 | ||
| Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. | Q54473910 | ||
| Cardiopoietic Stem Cell Therapy in Heart Failure | Q57779306 | ||
| Mesenchymal Stem Cells Provide Better Results Than Hematopoietic Precursors for the Treatment of Myocardial Infarction | Q59938198 | ||
| Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation | Q61776512 | ||
| Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart | Q64379356 | ||
| Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts | Q73791469 | ||
| Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction | Q80246358 | ||
| Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction | Q82270561 | ||
| Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction | Q83697673 | ||
| Overexpression of Kir2.1 channel in embryonic stem cell-derived cardiomyocytes attenuates posttransplantation proarrhythmic risk in myocardial infarction | Q87414968 | ||
| P433 | issue | 6 | |
| P921 | main subject | cell | Q7868 |
| circulatory system | Q11068 | ||
| heart failure | Q181754 | ||
| pluripotency | Q1894941 | ||
| regeneration | Q193119 | ||
| P304 | page(s) | 151 | |
| P577 | publication date | 2013-12-24 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons? | |
| P478 | volume | 4 |
| Q58036527 | 3D Micropillars Guide the Mechanobiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q32182693 | An Adult Mouse Thyroid Side Population Cell Line that Exhibits Enriched Epithelial-Mesenchymal Transition |
| Q43074474 | Cardiovascular regeneration |
| Q58762824 | Distinct Anti-Fibrotic Effects of Exosomes Derived from Endothelial Colony-Forming Cells Cultured Under Normoxia and Hypoxia |
| Q38541546 | Electrical stimulation to optimize cardioprotective exosomes from cardiac stem cells. |
| Q26765883 | Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide? |
| Q64055065 | Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure |
| Q64085300 | Potential role of exosomes in the pathophysiology, diagnosis, and treatment of hypoxic diseases |
| Q51358068 | Role of alpha- and beta-adrenergic receptors in cardiomyocyte differentiation from murine-induced pluripotent stem cells. |
| Q38543812 | Role of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease. |
| Q89146080 | Stem cells technology: a powerful tool behind new brain treatments |
| Q41248205 | Telocytes - a Hope for Cardiac Repair after Myocardial Infarction |
| Q36306176 | The acceleration of cardiomyogenesis in embryonic stem cells in vitro by serum depletion does not increase the number of developed cardiomyocytes |
| Q39285733 | Therapeutic application of multipotent stem cells |
| Q90952571 | Utility of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for an In Vitro Model of Proliferative Vitreoretinopathy |
Search more.